Evidence map›Paper›PMID 40103990›Full record

ArticleRSC advances2025

Detection of an oxidative stress metabolite associated with neurodegenerative diseases: effect of heteroatom doped antioxidant carbon dots.

Mohammad Tabish, Iram Malik, Abdulrahman M Alshahrani, Mohd Afzal

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad TabishDepartment of Pharmacology, College of Medicine, Shaqra University Shaqra 11961 Saudi Arabia tabish@su.edu.sa.ORCID https://orcid.org/0000-0001-8737-4088
Iram MalikDepartment of Electrical Engineering, College of Engineering, Prince Sattam Bin Abdulaziz University Al-Kharj 11942 Saudi Arabia.ORCID https://orcid.org/0000-0002-9242-9407
Abdulrahman M AlshahraniDepartment of Internal Medicine (Neurology), College of Medicine, Shaqra University Shaqra 11961 Saudi Arabia.ORCID https://orcid.org/0000-0001-8814-9333
Mohd AfzalDepartment of Chemistry, College of Science, King Saud University Riyadh 11451 Saudi Arabia maslam1@ksu.edu.sa.ORCID https://orcid.org/0000-0001-5668-6038

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon dots (CDs) are neoteric forms of carbon nanostructures, and play a fundamental role in early diagnosis and controlling of neurological disorders (NDs). Aiming towards the detection of an oxidative stress metabolite, the present study provides an innovative strategy for developing heteroatom-doped carbon dots using tamarind as a sustainable carbon source and urea as a nitrogen dopant through a one-step hydrothermal process. This method offers a cost-effective and eco-friendly solution without compromising performance. The structural and functional properties of the synthesized CDs were characterized using advanced techniques, including fluorescence spectroscopy, UV-visible spectroscopy, Fourier transform infrared (FTIR) spectroscopy, and X-ray photoelectron spectroscopy (XPS). Antioxidant assessments revealed remarkable free-radical scavenging activity (exceeding 80% efficiency) across three independent methodologies. Furthermore, the CDs demonstrated exceptional sensitivity and selectivity in detecting oxidative stress metabolites, particularly 3-nitrotyrosine, with detection efficiency influenced by environmental pH (4.8-8.7). Biocompatibility studies using fibroblast cells confirmed their non-toxic nature, supporting their potential for biomedical applications. Collectively, these findings highlight the promise of heteroatom-doped CDs as a novel platform for detecting oxidative stress metabolites associated with neurodegenerative diseases, bridging fundamental research with real-world diagnostic advancements.

Identifiers

PMID40103990
PMCPMC11917211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.